EV/EBITDA
-0.98
+0.02+2.00%
Wed, 27 Nov 2024 23:30:24 GMT
Summary:
Akari Therapeutics EV/EBITDA is currently -0.98, with a rise of +0.02 (+2.00%) during the most recent trading day. AKTX EV/EBITDA is now -406.25% below its all-time high of 0.32.AKTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKTX EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +2.0% |
| 3 m3 months | +68.3% |
| 6 m6 months | +31.0% |
| 1 y1 year | - |
| 5 y5 years | +60.6% |
AKTX EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -0.94 | -4.3% | -1.13 | +13.3% |
| 3 m | 3 months | -0.94 | -4.3% | -3.21 | +69.5% |
| 6 m | 6 months | -0.94 | -4.3% | -4.27 | +77.0% |
| 1 y | 1 year | -0.75 | -30.7% | -4.27 | +77.0% |
| 3 y | 3 years | -0.16 | -512.5% | -4.69 | +79.1% |
| 5 y | 5 years | -0.16 | -512.5% | -7.52 | +87.0% |
| alltime | all time | 0.32 | -406.3% | -13.49 | +92.7% |
Akari Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -0.98(-32.9%) |
| 2022 | -1.46(-59.4%) |
| 2021 | -3.60(+13.2%) |
| 2020 | -3.18(+60.6%) |
| 2019 | -1.98(+138.6%) |
| Date | Value |
|---|---|
| 2018 | -0.83(-23.1%) |
| 2017 | -1.08(-39.7%) |
| 2016 | -1.79(-25.7%) |
| 2015 | -2.41(-44.1%) |
| 2014 | -4.31 |
FAQ
- What is Akari Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Akari Therapeutics?
What is Akari Therapeutics EV/EBITDA?
The current EV/EBITDA of AKTX is -0.98
What is the all time high EV/EBITDA for Akari Therapeutics?
Akari Therapeutics all-time high EV/EBITDA is 0.32